Purveyors of dietary supplements, IV 'therapies,' and ozone 'therapies' were accused by the FTC of purporting that their products could fight COVID-19.
The mushroom-based ingredient can make licensed support claims on immune function, bone health, and general well-being in both adults and children in the Canadian marketplace.